Novokinin (Arg-Pro-Leu-Lys-Pro-Trp) is a potent hypotensive peptide previously designed based on the structure of ovokinin(2 7) (Arg-Ala-Asp-His-Pro-Phe), a vasorelaxing and hypotensive peptide derived from ovalbumin.
Similar to adding bulky-carbohydrate moieties to sulfonamides, steroid sulfatase inhibitors, which have been designed based on previously seen antimitotic inhibitors [ 136, 137] are able to take advantage of the variable residues in the hydrophobic pocket of specific CAs via van Der Waals contacts of the steroidal backbone [ 136– 136].
A sample composition has been designed based on previously reported data.
To this end, 5679 secondary school students from six European countries (Spain, Germany, Italy, Poland, United Kingdom, and Greece) were surveyed through this self-report questionnaire which was designed based on previously existing instruments and the most relevant conceptual elements.
TaqMan probes and proprietary primers were designed based on previously reported sequences were purchased from ABI (Foster City, CA).
A measurement system has been designed based on a similar principle to one previously described.
Our prototype PTL was designed based on previously published GABAAR probes in which the pharmacophore muscimol is conjugated to a fluorophore or biotin via a 6-aminohexanoyl spacer.
Analogues were designed based on a lead compound that was previously determined to have selective activity as a GPR35 antagonist.
This array is comprised of 385,000 probes evenly distributed throughout the unique sequence of the genome as a backbone and an additional ~330,000 probes which were designed based on previously reported dog CNV regions [ 14].
